TechNation / Israel Election App Plagued With Glitches

Yesh Atid website was No. 1 among voters; CollPlant stock jumps on drug trial news.

Election app plagued with glitches

Users of the government’s smartphone election app, “Bechiron,” which came in for criticism when it was launched for not being available in Arabic, an official language of the country, encountered technical glitches on Election Day. An Arabic version was added prior to Election Day to the app, which in addition to providing information about the parties on the ballot, included a feature providing information about the location of polling stations and real-time detail on the results. But on the day of the vote, during the morning and afternoon, the polling place information was not working on the app or on the Central Election Committee’s general website. (Amitai Ziv)

Yesh Atid website was No. 1 among voters

Yair Lapid’s Yesh Atid party was more successful in attracting members of the public to its website than any other Israeli political party during the Knesset election campaign, the data company SimilarWeb reported. The party also managed to attract 3.8 times the traffic in the last week of the campaign compared to the same week in February. Last week the Yesh Atid site attracted about 17,000 unique viewers per day on average, four times the traffic to the Habayit Hayehudi website and twice the traffic to the Zionist Union’s site. Although it had been expected that traffic to the sites would surge as Election Day neared, the surge in traffic to the Yesh Atid website was greater, although Habayit Hayehudi also experienced substantially increased traffic to its website. Last week the Likud website attracted an average of 3,300 views a day. (Amitai Ziv)

CollPlant stock jumps on drug trial news

Shares of the medical firm CollPlant jumped yesterday on news of success of a middle-stage clinical trial at health clinics in Israel of a gel that promotes healing of chronic sores and surgical incisions that have resisted other kinds of treatment. The patients in the trial received one treatment with the product, Vergenix, and then were given four months of follow-up monitoring. CollPlant, which is based in Nes Tziona, reported that wounds closed by 80% to 100% in the vast majority of patients. (Yoram Gabison)